Logo image of HLI

HOULIHAN LOKEY INC (HLI) Stock Fundamental Analysis

NYSE:HLI - New York Stock Exchange, Inc. - US4415931009 - Common Stock - Currency: USD

150.2  -3.08 (-2.01%)

After market: 150.2 0 (0%)

Fundamental Rating

6

Taking everything into account, HLI scores 6 out of 10 in our fundamental rating. HLI was compared to 227 industry peers in the Capital Markets industry. HLI has an average financial health and profitability rating. HLI is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make HLI suitable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year HLI was profitable.
HLI had a positive operating cash flow in the past year.
HLI had positive earnings in each of the past 5 years.
HLI had a positive operating cash flow in each of the past 5 years.
HLI Yearly Net Income VS EBIT VS OCF VS FCFHLI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

With an excellent Return On Assets value of 10.32%, HLI belongs to the best of the industry, outperforming 88.11% of the companies in the same industry.
With an excellent Return On Equity value of 17.25%, HLI belongs to the best of the industry, outperforming 81.94% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 16.91%, HLI belongs to the top of the industry, outperforming 93.83% of the companies in the same industry.
HLI had an Average Return On Invested Capital over the past 3 years of 20.04%. This is significantly above the industry average of 7.09%.
Industry RankSector Rank
ROA 10.32%
ROE 17.25%
ROIC 16.91%
ROA(3y)10.86%
ROA(5y)11.28%
ROE(3y)20.45%
ROE(5y)20.52%
ROIC(3y)20.04%
ROIC(5y)19.66%
HLI Yearly ROA, ROE, ROICHLI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of HLI (16.00%) is comparable to the rest of the industry.
HLI's Profit Margin has been stable in the last couple of years.
With a Operating Margin value of 21.61%, HLI perfoms like the industry average, outperforming 43.61% of the companies in the same industry.
In the last couple of years the Operating Margin of HLI has remained more or less at the same level.
Industry RankSector Rank
OM 21.61%
PM (TTM) 16%
GM N/A
OM growth 3Y-10.86%
OM growth 5Y-1.27%
PM growth 3Y-10.62%
PM growth 5Y-0.04%
GM growth 3YN/A
GM growth 5YN/A
HLI Yearly Profit, Operating, Gross MarginsHLI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

The number of shares outstanding for HLI has been increased compared to 1 year ago.
HLI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, HLI has a worse debt to assets ratio.
HLI Yearly Shares OutstandingHLI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
HLI Yearly Total Debt VS Total AssetsHLI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

HLI has an Altman-Z score of 6.21. This indicates that HLI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.21, HLI belongs to the top of the industry, outperforming 90.31% of the companies in the same industry.
The Debt to FCF ratio of HLI is 0.02, which is an excellent value as it means it would take HLI, only 0.02 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.02, HLI belongs to the top of the industry, outperforming 92.51% of the companies in the same industry.
HLI has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of HLI (0.01) is better than 85.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.02
Altman-Z 6.21
ROIC/WACCN/A
WACCN/A
HLI Yearly LT Debt VS Equity VS FCFHLI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

HLI has a Current Ratio of 0.88. This is a bad value and indicates that HLI is not financially healthy enough and could expect problems in meeting its short term obligations.
HLI has a Current ratio of 0.88. This is comparable to the rest of the industry: HLI outperforms 42.29% of its industry peers.
HLI has a Quick Ratio of 0.88. This is a bad value and indicates that HLI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.88, HLI is in line with its industry, outperforming 42.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.88
HLI Yearly Current Assets VS Current LiabilitesHLI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.16% over the past year.
The Earnings Per Share has been growing by 9.29% on average over the past years. This is quite good.
HLI shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.01%.
Measured over the past years, HLI shows a quite strong growth in Revenue. The Revenue has been growing by 12.04% on average per year.
EPS 1Y (TTM)29.16%
EPS 3Y-0.73%
EPS 5Y9.29%
EPS Q2Q%34.43%
Revenue 1Y (TTM)22.01%
Revenue growth 3Y7.86%
Revenue growth 5Y12.04%
Sales Q2Q%24.12%

3.2 Future

Based on estimates for the next years, HLI will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.11% on average per year.
HLI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.25% yearly.
EPS Next Y33.64%
EPS Next 2Y23.33%
EPS Next 3Y20.29%
EPS Next 5Y18.11%
Revenue Next Year23.43%
Revenue Next 2Y17.46%
Revenue Next 3Y14.78%
Revenue Next 5Y13.25%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HLI Yearly Revenue VS EstimatesHLI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
HLI Yearly EPS VS EstimatesHLI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8

4

4. Valuation

4.1 Price/Earnings Ratio

HLI is valuated quite expensively with a Price/Earnings ratio of 26.87.
HLI's Price/Earnings ratio is a bit more expensive when compared to the industry. HLI is more expensive than 70.04% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.63. HLI is around the same levels.
A Price/Forward Earnings ratio of 21.99 indicates a rather expensive valuation of HLI.
Based on the Price/Forward Earnings ratio, HLI is valued a bit more expensive than the industry average as 63.00% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.85, HLI is valued at the same level.
Industry RankSector Rank
PE 26.87
Fwd PE 21.99
HLI Price Earnings VS Forward Price EarningsHLI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HLI is valued a bit cheaper than the industry average as 72.69% of the companies are valued more expensively.
62.56% of the companies in the same industry are more expensive than HLI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.54
EV/EBITDA 19.2
HLI Per share dataHLI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HLI has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as HLI's earnings are expected to grow with 20.29% in the coming years.
PEG (NY)0.8
PEG (5Y)2.89
EPS Next 2Y23.33%
EPS Next 3Y20.29%

5

5. Dividend

5.1 Amount

HLI has a Yearly Dividend Yield of 1.49%.
HLI's Dividend Yield is slightly below the industry average, which is at 8.41.
With a Dividend Yield of 1.49, HLI pays less dividend than the S&P500 average, which is at 2.51.
Industry RankSector Rank
Dividend Yield 1.49%

5.2 History

The dividend of HLI is nicely growing with an annual growth rate of 16.14%!
HLI has been paying a dividend for at least 10 years, so it has a reliable track record.
As HLI did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)16.14%
Div Incr Years9
Div Non Decr Years9
HLI Yearly Dividends per shareHLI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

45.21% of the earnings are spent on dividend by HLI. This is a bit on the high side, but may be sustainable.
HLI's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP45.21%
EPS Next 2Y23.33%
EPS Next 3Y20.29%
HLI Yearly Income VS Free CF VS DividendHLI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
HLI Dividend Payout.HLI Dividend Payout, showing the Payout Ratio.HLI Dividend Payout.PayoutRetained Earnings

HOULIHAN LOKEY INC

NYSE:HLI (4/21/2025, 8:19:40 PM)

After market: 150.2 0 (0%)

150.2

-3.08 (-2.01%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)01-28 2025-01-28/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners103.38%
Inst Owner Change1.47%
Ins Owners0.13%
Ins Owner Change-1.3%
Market Cap10.54B
Analysts69.23
Price Target195.84 (30.39%)
Short Float %1.44%
Short Ratio1.89
Dividend
Industry RankSector Rank
Dividend Yield 1.49%
Yearly Dividend2.15
Dividend Growth(5Y)16.14%
DP45.21%
Div Incr Years9
Div Non Decr Years9
Ex-Date03-03 2025-03-03 (0.57)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.74%
Min EPS beat(2)7.29%
Max EPS beat(2)10.19%
EPS beat(4)4
Avg EPS beat(4)5.09%
Min EPS beat(4)0.24%
Max EPS beat(4)10.19%
EPS beat(8)7
Avg EPS beat(8)4.66%
EPS beat(12)10
Avg EPS beat(12)6.05%
EPS beat(16)14
Avg EPS beat(16)11.68%
Revenue beat(2)2
Avg Revenue beat(2)5.07%
Min Revenue beat(2)4.31%
Max Revenue beat(2)5.83%
Revenue beat(4)3
Avg Revenue beat(4)2.84%
Min Revenue beat(4)-0.03%
Max Revenue beat(4)5.83%
Revenue beat(8)6
Avg Revenue beat(8)1.84%
Revenue beat(12)9
Avg Revenue beat(12)2.21%
Revenue beat(16)12
Avg Revenue beat(16)8.16%
PT rev (1m)-1.79%
PT rev (3m)2.31%
EPS NQ rev (1m)-0.89%
EPS NQ rev (3m)3.32%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)4.25%
Revenue NQ rev (1m)-0.5%
Revenue NQ rev (3m)3.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.72%
Valuation
Industry RankSector Rank
PE 26.87
Fwd PE 21.99
P/S 4.7
P/FCF 15.54
P/OCF 14.72
P/B 5.06
P/tB 18.22
EV/EBITDA 19.2
EPS(TTM)5.59
EY3.72%
EPS(NY)6.83
Fwd EY4.55%
FCF(TTM)9.67
FCFY6.44%
OCF(TTM)10.2
OCFY6.79%
SpS31.99
BVpS29.66
TBVpS8.24
PEG (NY)0.8
PEG (5Y)2.89
Profitability
Industry RankSector Rank
ROA 10.32%
ROE 17.25%
ROCE 22.51%
ROIC 16.91%
ROICexc 26.88%
ROICexgc N/A
OM 21.61%
PM (TTM) 16%
GM N/A
FCFM 30.23%
ROA(3y)10.86%
ROA(5y)11.28%
ROE(3y)20.45%
ROE(5y)20.52%
ROIC(3y)20.04%
ROIC(5y)19.66%
ROICexc(3y)39.11%
ROICexc(5y)39.19%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)26.67%
ROCE(5y)26.17%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-23.15%
ROICexc growth 5Y-1.65%
OM growth 3Y-10.86%
OM growth 5Y-1.27%
PM growth 3Y-10.62%
PM growth 5Y-0.04%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.02
Debt/EBITDA 0.03
Cap/Depr 109.73%
Cap/Sales 1.67%
Interest Coverage 354.44
Cash Conversion 137.87%
Profit Quality 188.95%
Current Ratio 0.88
Quick Ratio 0.88
Altman-Z 6.21
F-Score9
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)112.97%
Cap/Depr(5y)110.26%
Cap/Sales(3y)2.22%
Cap/Sales(5y)1.88%
Profit Quality(3y)97.77%
Profit Quality(5y)123.89%
High Growth Momentum
Growth
EPS 1Y (TTM)29.16%
EPS 3Y-0.73%
EPS 5Y9.29%
EPS Q2Q%34.43%
EPS Next Y33.64%
EPS Next 2Y23.33%
EPS Next 3Y20.29%
EPS Next 5Y18.11%
Revenue 1Y (TTM)22.01%
Revenue growth 3Y7.86%
Revenue growth 5Y12.04%
Sales Q2Q%24.12%
Revenue Next Year23.43%
Revenue Next 2Y17.46%
Revenue Next 3Y14.78%
Revenue Next 5Y13.25%
EBIT growth 1Y38.24%
EBIT growth 3Y-3.85%
EBIT growth 5Y10.62%
EBIT Next Year45.75%
EBIT Next 3Y23.71%
EBIT Next 5YN/A
FCF growth 1Y1067.32%
FCF growth 3Y-22.66%
FCF growth 5Y3.76%
OCF growth 1Y2013.2%
OCF growth 3Y-17.26%
OCF growth 5Y7.93%